Kolexia
Devillier Raynier Hématologie
Devillier Raynier
Hématologie
Centre Paoli-Calmettes
Marseille, France
234 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémie aigüe myéloïde Maladie du greffon contre l'hôte Leucémies Leucémie myéloïde Lymphomes Maladie de Hodgkin Tumeurs hématologiques Syndromes myélodysplasiques Maladie chronique

Collaborateurs

Voir plus
Blaise Didier
Blaise Didier
Centre Paoli-Calmettes, Marseille, France
Furst Sabine
Furst Sabine
Centre Paoli-Calmettes, Marseille, France
Chabannon Christian
Chabannon Christian
Centre Paoli-Calmettes, Marseille, France
Harbi Samia
Harbi Samia
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
MEDAC SAS
10 collaboration(s)
Dernière en 2023
Neovii
8 collaboration(s)
Dernière en 2023
MSD
5 collaboration(s)
Dernière en 2023
Astellas
4 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
A Single Center Real World Experience of Allogeneic HSCT of Patients with MDS/CMML in Aged Population
Abstracts from the 2024 Tandem Meetings of ASTCT and CIBMTR, February 21-24, 2024, San Antonio, Texas, USA   01 février 2024
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
Journal of hematology & oncology   07 janvier 2024
FLUCLORIC: Randomized Multicentric Phase III Study Comparing the Efficacy of 2 Reduced Intensity Conditioning Regimens (Clofarabine/Busulfan vs Fludarabine/Busulfan) in Adults With AML and Eligible to Allogeneic Stem Cell Transplantation
Essai Clinique (CHU Nantes)   13 novembre 2023
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Cancer chemotherapy and pharmacology   13 novembre 2023
Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial): A Multi-center Randomized, Double Blinded Phase IIb Trial Evaluating Oral Pooled Fecal Microbiotherapy MaaT033 to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)
Essai Clinique (MaaT Pharma)   06 novembre 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Bone marrow transplantation   03 novembre 2023
Current Results of Intensive Therapy in Younger Adults with Acute Myeloid Leukemia (AML): The Large Randomized French Backbone Intergroup (BIG)-1 Study on Behalf of the Filo, ALFA, and SFGM-TC Study Groups
65th ASH Annual Meeting Abstracts   02 novembre 2023
TIM-3 Inhibitor Sabatolimab for Patients with Acute Myeloid Leukemia (AML) with Measurable Residual Disease (MRD) Detected after Allogeneic Stem Cell Transplantation (AlloSCT): Preliminary Findings from the Phase Ib/II Stimulus-AML2 Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Allogeneic Hematopoietic Cell Transplantation in the Elderly Results in Similar Survival with Matched Related or Unrelated and Haploidentical Donors: A Report from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Comparison of Two Reduced Intensity Conditioning Regimens (Baltimore with Clofarabine vs Thiotepa-Busulfan-Fludarabine) in Adults Receiving Peripheral Blood Stem Cell Haploidentical Transplantation for Myeloid Malignancies: A Retrospective Study of the SFGM-TC
65th ASH Annual Meeting Abstracts   02 novembre 2023